Adaptation of international coronavirus disease 2019 and breast cancer guidelines to local context

作     者：Guillermo Arturo Valencia Silvia Neciosup Henry L Gómez Maria Del Pilar Benites Silvia Falcón David Moron Karin Veliz Mike Maldonado Rodrigo Auqui 

作者机构：Department of Medical OncologyInstituto Nacional de Enfermedades Neoplásicas(INEN)Surquillo 15000LimaPeru Clínica Oncosalud–AUNASurquillo 15000LimaPeru Breast Cancer UnitHospital Nacional Edgardo Rebagliati MartinsLima 15000Peru Department of Medical OncologyCentro Oncológico AliadaLima 15000Peru Department of Medical OncologyHospital Nacional Carlos Alberto Seguín EscobedoArequipa 04001Peru Department of Medical OncologyHospital Nacional Ramiro PrialéPrialéHuancayo 12000Peru Department of Medical OncologyInstituto Regional de Enfermedades Neoplásicas(IREN)Trujillo 13001Peru Department of Medical OncologyHospital Nacional Almanzor Aguinaga AsenjoChiclayo 14001Peru 

出 版 物：《World Journal of Clinical Oncology》 (世界临床肿瘤学杂志（英文版）)

年 卷 期：2021年第12卷第1期

页      面：31-42页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 100214[医学-肿瘤学] 10[医学] 

主　　题：Breast cancer COVID-19 Guidelines Recommendations Oncology Medical treatment 

摘      要：BACKGROUND The coronavirus disease 2019(COVID-19)pandemic caused by severe acute respiratory syndrome coronavirus 2(a novel coronavirus),which was first identified amid an outbreak of respiratory illness cases in Wuhan,China and declared a global health emergency,is currently considered an additional challenge in the management of patients with breast cancer(BC).Cancer patients are more vulnerable to becoming infected with severe acute respiratory syndrome coronavirus 2 and are more likely to suffer additional complications that can increase *** those BC patients who require more urgent therapy than others in the current situation is *** recommendations are based on and have been adapted from those similarly published by international scientific societies for BC *** are divided mainly by clinical stage(early,advanced),subtype[luminal,human epidermal growth factor receptor 2(HER2),triple-negative],or type of medical treatment and setting(neoadjuvant,adjuvant,metastatic).Recommendations for HER2 and triplenegative subtypes are similar,whereas in luminal subtype there are various options of *** objective is to adapt guidelines to local context through relevant decision-makers,avoiding duplication of efforts and optimizing use or *** hope that these recommendations will help medical oncologists provide the best quality care to BC patients during the COVID-19 pandemic with information tailored to our healthcare *** To establish and adapt recommendations from those published by international scientific societies for BC *** The Peruvian Society of Medical Oncology developed a consensus and propose here a manuscript with recommendations for oncological medical treatment of BC during the COVID-19 *** Peruvian Society of Medical Oncology invited a panel of experts and opinion leaders on BC working in major health care systems around *** experts selected three international clin